Encrypted | Login

Working Group on Iodine-131 Radiopharmaceutical Therapies (WGI131)

AAPM Members, Affiliates and Non-Member Affiliates - Login for access to additional information

Activities
  1. Guidelines and Recommendations: Review Iodine-131 (I-131) radiopharmaceutical therapy (RPT) clinical practices and address emerging scientific and clinical topics.
  2. Knowledge and education: Summarize knowledge about general principles and rationale for I-131 RPT. Identify opportunities for and timely implement education and training initiatives.
  3. Repository: Review published materials on I-131 RPT and develop a repository of abstracts. Coordinate with clinical trial groups, such as IROC Houston, to document consensus dosimetry data for I-131 RPT.
  4. Clinical translation: Organize, review and disseminate known practices on clinical translations of I-131 RPT.
  5. Communication: Serve as an ongoing central resource and conduit for multi-disciplinary professional organizations, regulatory bodies, vendors, standards labs and the international community relating to recommended guidelines, best practices, and future directions for research and development of I-131 RPT.
  6. Coordination: Oversee and direct AAPM efforts related to I-131 RPT. Specifically, create and advise Task Groups, Medical Physics Practice Guidelines and other AAPM initiatives, as deemed necessary, with the changes in the clinical practice of I-131 RPT.
  7. Innovation: Support new developments in the field of I-131 RPT. Such developments are likely in the areas of clinical implementation of new I-131 RPTs, dosimetry, imaging, and patient release to list a few examples.
By-Laws:Not Referenced.Rules: Not Referenced.
Standing?This is not a standing committee.
Approved Date(s):3/30/2023
Committee Keywords: No Keywords Entered

Board of Directors
Science Council
Therapy Physics Cmte  [Status]
Radiopharmaceutical Therapy SC  [Status]
Working Group on Iodine-131 Radiopharmaceutical Therapies  [Status]

» Conflict of Interest report for WGI131
» Status Reports for Task Groups - AC | EC | IC | PC | SC | Board Committees | All
Chair

Nichole Maughan
Workgroup Chair

2025 Roster

(dates shown below are start and end dates of position.)

= complete and up-to-date
= up-to-date but expires soon
= incomplete or out of date conflict of interest statement.

VOTING AppointmentsThere are 8 voting members.

up-to-dateWesley E. Bolch, PhD

3/30/2023 - 12/31/2025 Member
up-to-dateKenneth W. Cashon, MS

5/18/2023 - 12/31/2025 Member

up-to-dateSven L. Gallo, MS

1/1/2024 - 12/31/2026 Work Group Vice Chair
up-to-dateRobert F. Hobbs, PhD

3/30/2023 - 12/31/2025 Member

up-to-dateStephanie M. Leon, PhD

3/19/2024 - 12/31/2026 Member
up-to-dateNichole M. Maughan, PhD

3/30/2023 - 12/31/2025 Workgroup Chair

up-to-dateXingyu Nie, PhD

5/18/2023 - 12/31/2025 Member
up-to-dateWendy Siman, PhD

7/10/2024 - 12/31/2027 Member
NON-VOTING AppointmentsThere are 1 non-voting members and guests.

up-to-dateWilliam D. Erwin, MS

3/19/2024 - 12/31/2026 Guest (nonvoting)
HQ Team Appointed to CommitteeThere are 0 staff.



See connections to Working Group on Iodine-131 Radiopharmaceutical Therapies (WGI131)